Related references
Note: Only part of the references are listed.Neuroprotective Effects of Purpurin Against Ischemic Damage via MAPKs, Bax, and Oxidative Stress Cascades in the Gerbil Hippocampus
Woosuk Kim et al.
MOLECULAR NEUROBIOLOGY (2022)
Engineered Wnt ligands enable blood-brain barrier repair in neurological disorders
Maud Martin et al.
SCIENCE (2022)
Role of Nuclear-Receptor-Related 1 in the Synergistic Neuroprotective Effect of Umbilical Cord Blood and Erythropoietin Combination Therapy in Hypoxic Ischemic Encephalopathy
Joo-Wan Choi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Physiological and pharmacological modulation of BAX
Adam Z. Spitz et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2022)
Activation of Wnt/Beta-Catenin Signaling Pathway as a Promising Therapeutic Candidate for Cerebral Ischemia/Reperfusion Injury
Zhizhun Mo et al.
FRONTIERS IN PHARMACOLOGY (2022)
Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities
Jiaqi Liu et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2022)
Wnt/β-Catenin Signaling in Neural Stem Cell Homeostasis and Neurological Diseases
Juanmei Gao et al.
NEUROSCIENTIST (2021)
GSK-3β inhibitor TWS119 alleviates hypoxic-ischemic brain damage via a crosstalk with Wnt and Notch signaling pathways in neonatal rats
Limin Gao et al.
BRAIN RESEARCH (2021)
Association of Increased Seizures During Rewarming With Abnormal Neurodevelopmental Outcomes at 2-Year Follow-up A Nested Multisite Cohort Study
Lina F. Chalak et al.
JAMA NEUROLOGY (2021)
Free Radicals and Neonatal Brain Injury: From Underlying Pathophysiology to Antioxidant Treatment Perspectives
Silvia Martini et al.
ANTIOXIDANTS (2021)
Neuropeptides in the developing human hippocampus under hypoxic-ischemic conditions
Joaquin Gonzalez Fuentes et al.
JOURNAL OF ANATOMY (2021)
Activation of liver X receptor promotes hippocampal neurogenesis and improves long-term cognitive function recovery in acute cerebral ischemia-reperfusion mice
Lili Chen et al.
JOURNAL OF NEUROCHEMISTRY (2020)
Hypoxic-ischemic-related cerebrovascular changes and potential therapeutic strategies in the neonatal brain
Clemence Disdier et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2020)
Oxymatrine exerts organ- and tissue-protective effects by regulating inflammation, oxidative stress, apoptosis, and fibrosis: From bench to bedside
Xu Lan et al.
PHARMACOLOGICAL RESEARCH (2020)
Oligodendrocyte precursor cells transplantation protects blood-brain barrier in a mouse model of brain ischemia via Wnt/β-catenin signaling
Liping Wang et al.
CELL DEATH & DISEASE (2020)
Overexpression of apoptosis inducing factor aggravates hypoxic-ischemic brain injury in neonatal mice
Tao Li et al.
CELL DEATH & DISEASE (2020)
Current Evidence on Cell Death in Preterm Brain Injury in Human and Preclinical Models
Anita C. Truttmann et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Hypoxic-Ischemic Encephalopathy and Mitochondrial Dysfunction: Facts, Unknowns, and Challenges
Marianela Rodriguez et al.
ANTIOXIDANTS & REDOX SIGNALING (2020)
Targeting the Wnt/β-catenin pathway in neurodegenerative diseases: recent approaches and current challenges
Annalucia Serafino et al.
EXPERT OPINION ON DRUG DISCOVERY (2020)
Repression of long non-coding RNA MEG3 restores nerve growth and alleviates neurological impairment after cerebral ischemia-reperfusion injury in a rat model
Dong You et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
FCPR03, a novel phosphodiesterase 4 inhibitor, alleviates cerebral ischemia/reperfusion injury through activation of the AKT/GSK313/ β-catenin signaling pathway
Bingtian Xu et al.
BIOCHEMICAL PHARMACOLOGY (2019)
Hypoxic postconditioning activates the Wnt/β-catenin pathway and protects against transient global cerebral ischemia through Dkk1 Inhibition and GSK-3β inactivation
Lixuan Zhan et al.
FASEB JOURNAL (2019)
Molecular and topological reorganizations in mitochondrial architecture interplay during Bax-mediated steps of apoptosis
Nicholas R. Ader et al.
ELIFE (2019)
The role of DKK1 in Alzheimer's disease: A potential intervention point of brain damage prevention?
Chao Ren et al.
PHARMACOLOGICAL RESEARCH (2019)
XQ-1H alleviates cerebral ischemia in mice through inhibition of apoptosis and promotion of neurogenesis in a Wnt/β-catenin signaling dependent way
Dan Xu et al.
LIFE SCIENCES (2019)
The role of Wnt/β-catenin pathway in the protection process by dexmedetomidine against cerebral ischemia/reperfusion injury in rats
Ping Li et al.
LIFE SCIENCES (2019)
Therapeutic Hypothermia in Neonatal Hypoxic-Ischemic Encephalopathy
Guido Wassink et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2019)
Targeting nuclear β-catenin as therapy for post-myeloproliferative neoplasm secondary AML
Dyana T. Saenz et al.
LEUKEMIA (2019)
Plasma Biomarkers of Brain Injury in Neonatal Hypoxic-Ischemic Encephalopathy
An N. Massaro et al.
JOURNAL OF PEDIATRICS (2018)
Vitamin A bio-modulates apoptosis via the mitochondrial pathway after hypoxic-ischemic brain damage
Wei Jiang et al.
MOLECULAR BRAIN (2018)
Neonatal hypoxic ischemic encephalopathy: an update on disease pathogenesis and treatment
Edibe Pembegul Yildiz et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2017)
Neonatal hypoxic ischemic encephalopathy: an update on disease pathogenesis and treatment
Edibe Pembegul Yildiz et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2017)
Connecting mitochondrial dynamics and life-or-death events via Bcl-2 family proteins
Abdel Aouacheria et al.
NEUROCHEMISTRY INTERNATIONAL (2017)
Survival and Neurodevelopmental Outcomes among Periviable Infants
Noelle Younge et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Mitochondrial function in hypoxic ischemic injury and influence of aging
P. Benson Ham et al.
PROGRESS IN NEUROBIOLOGY (2017)
Cell Death in the Developing Brain after Hypoxia-Ischemia
Claire Thornton et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2017)
Early diagnosis and outcome prediction of neonatal hypoxic-ischemic encephalopathy with color Doppler ultrasound
B. Guan et al.
DIAGNOSTIC AND INTERVENTIONAL IMAGING (2017)
Protein S100B in umbilical cord blood as a potential biomarker of hypoxic-ischemic encephalopathy in asphyxiated newborns
Mehreen Zaigham et al.
EARLY HUMAN DEVELOPMENT (2017)
The role of the Wnt canonical signaling in neurodegenerative diseases
Rosaliana Libro et al.
LIFE SCIENCES (2016)
Oxymatrine attenuated hypoxic-ischemic brain damage in neonatal rats via improving antioxidant enzyme activities and inhibiting cell death
Peng Zhao et al.
NEUROCHEMISTRY INTERNATIONAL (2015)
GENOMIC APPROACH TO SELECTIVE VULNERABILITY OF THE HIPPOCAMPUS IN BRAIN ISCHEMIA-HYPOXIA
Rainald Schmidt-Kastner
NEUROSCIENCE (2015)
Hypoxic-Ischemic Encephalopathy A Review for the Clinician
Martha Douglas-Escobar et al.
JAMA PEDIATRICS (2015)
Pomegranate extract protects against cerebral ischemia/reperfusion injury and preserves brain DNA integrity in rats
Maha A. E. Ahmed et al.
LIFE SCIENCES (2014)
Wnt Proteins
Karl Willert et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2012)
TCF/LEFs and Wnt Signaling in the Nucleus
Ken M. Cadigan et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2012)
GSK3 beta: role in therapeutic landscape and development of modulators
S. Phukan et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
GSK3: a multifaceted kinase in Wnt signaling
Dianqing Wu et al.
TRENDS IN BIOCHEMICAL SCIENCES (2010)
Glycogen synthase kinase-3 beta/beta-catenin promotes angiogenic and anti-apoptotic signaling through the induction of VEGF, Bcl-2 and survivin expression in rat ischemic preconditioned myocardium
S Kaga et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2006)
Perinatal hypoxic-ischemic brain damage: Evolution of an animal model
RC Vannucci et al.
DEVELOPMENTAL NEUROSCIENCE (2005)
Increased susceptibility of S100B transgenic mice to perinatal hypoxia-ischemia
MS Wainwright et al.
ANNALS OF NEUROLOGY (2004)
DKK1, a negative regulator of Wnt signaling, is a target of the β-catenin/TCF pathway
A Niida et al.
ONCOGENE (2004)
Comet assay as a novel approach for studying DNA damage in focal cerebral ischemia: Differential effects of NMDA receptor antagonists and poly(ADP-ribose) polymerase inhibitors
L Giovannelli et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2002)
The nonsteroidal anti-inflammatory drugs aspirin and indomethacin attenuate β-catenin/TCF-4 signaling
S Dihlmann et al.
ONCOGENE (2001)